Subgroup PFS analysis based on treatment intention. Kaplan-Meier subgroup PFS analysis assessed from date of diagnosis comparing chemotherapy-alone (chemo) vs CMT. (A) Bulky disease. (B) Unfavorable disease. (C) Non-bulky disease. (D) Favorable disease.